We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Corebridge Financial
CRBG
$14.1B
| $33.3M | 0.07% |
2,076,452
+256,046
| +14% | +$5.02M |
|
|
NEWR
302
DELISTED
New Relic, Inc.
NEWR
| $32.7M | 0.07% |
434,692
-101,525
| -19% | -$6.86M |
|
|
DAY
303
DELISTED
Dayforce
DAY
| $32.3M | 0.07% |
441,088
+99,953
| +29% | +$7.09M |
|
304
Celsius Holdings
CELH
$6.93B
| $31.9M | 0.07% |
1,030,548
+313,449
| +44% | +$9.89M |
|
305
Electronic Arts
EA
$52.4B
| $31.8M | 0.07% |
264,085
-33,254
| -11% | -$3.91M |
|
306
Tidewater
TDW
$3.91B
| $31.8M | 0.07% |
721,128
-320,231
| -31% | -$13.8M |
|
307
AstraZeneca
AZN
$263B
| $31.7M | 0.07% |
228,575
-940,045
| -80% | -$126M |
|
308
Protagonist Therapeutics
PTGX
$8.75B
| $31.4M | 0.07% |
1,366,080
-88,366
| -6% | -$1.48M |
|
309
Repligen
RGEN
$7.44B
| $31.4M | 0.07% |
186,229
+123,078
| +195% | +$22M |
|
310
Telefônica Brasil
VIV
$22.4B
| $31.2M | 0.07% |
4,117,212
-1,555,026
| -27% | -$11.7M |
|
311
MakeMyTrip
MMYT
$4.67B
| $30.9M | 0.07% |
1,263,006
-92,588
| -7% | -$2.46M |
|
312
Xponential Fitness
XPOF
$265M
| $30.8M | 0.07% |
1,015,110
+636,356
| +168% | +$16.8M |
|
313
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $30.7M | 0.07% |
355,963
+245,176
| +221% | +$21.1M |
|
314
Clorox
CLX
$11.6B
| $30.4M | 0.06% |
191,828
+56,782
| +42% | +$8.52M |
|
315
GXO Logistics
GXO
$6.06B
| $30.1M | 0.06% |
596,615
+169,415
| +40% | +$8.43M |
|
316
Ormat Technologies
ORA
$6.11B
| $30.1M | 0.06% |
+354,833
| New | +$31.1M |
|
317
Fortune Brands Innovations
FBIN
$6.12B
| $29.9M | 0.06% |
509,653
+189,150
| +59% | +$11.6M |
|
318
Comcast
CMCSA
$79.1B
| $29.9M | 0.06% |
788,585
+493,171
| +167% | +$18.6M |
|
319
Omega Healthcare
OHI
$15.4B
| $29.9M | 0.06% |
1,090,491
+268,071
| +33% | +$7.46M |
|
320
Weatherford International
WFRD
$6.36B
| $29.9M | 0.06% |
503,424
+499,124
| +11,608% | +$29.2M |
|
321
PUT
iShares China Large-Cap ETF
FXI
$4.31B
| $29.9M | 0.06% |
1,011,300
+512,000
| +103% | +$15.4M |
|
322
Western Digital
WDC
$179B
| $29.7M | 0.06% |
1,043,555
+1,004,411
| +2,566% | +$29.5M |
|
323
Hasbro
HAS
$12.6B
| $29.7M | 0.06% |
+552,968
| New | +$31.6M |
|
324
KBR
KBR
$4.68B
| $29.6M | 0.06% |
538,211
-192,467
| -26% | -$10.1M |
|
|
325
CALL
Amazon
AMZN
$2.5T
| $29.3M | 0.06% |
284,000
-50,000
| -15% | -$4.83M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.